Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Tatoud

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Emerging Microbes & Infections|July 23, 2024
Biotech's role in advancing HIV vaccine developmentRoger Tatoud, Christian Brander, Carey Hwang, et al.
Plos One|January 28, 2014
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimenPaul F McKay, Alethea V Cope, Jamie F S Mann, et al.
Differentiation; Research in Biological Diversity|January 25, 2007
A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiationBernadette Daly-Burns, Tahirah N Alam, Alan Mackay, et al.
Journal of the International AIDS Society|February 9, 2022
Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19Merle Henderson, Sarah Fidler, Beatriz Mothe, et al.
Cancer Research|May 6, 2004
Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell linesRuth L Stephen, Mattias C U Gustafsson, Morag Jarvis, et al.
Plos One|February 28, 2008
Phylometabonomic patterns of adaptation to high fat diet feeding in inbred miceJane F Fearnside, Marc-Emmanuel Dumas, Alice R Rothwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2006
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant miceMarc-Emmanuel Dumas, Richard H Barton, Ayo Toye, et al.
Plos One|May 19, 2016
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I TrialAgricola Joachim, Asli Bauer, Sarah Joseph, et al.
Frontiers in Immunology|March 10, 2017
A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization RegimesSarah Joseph, Killian Quinn, Aldona Greenwood, et al.
Frontiers in Immunology|May 21, 2019
Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and SequenceYuka Nadai, Kathrin Held, Sarah Joseph, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Emerging Microbes & Infections|July 23, 2024
Biotech's role in advancing HIV vaccine developmentRoger Tatoud, Christian Brander, Carey Hwang, et al.
Plos One|January 28, 2014
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimenPaul F McKay, Alethea V Cope, Jamie F S Mann, et al.
Differentiation; Research in Biological Diversity|January 25, 2007
A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiationBernadette Daly-Burns, Tahirah N Alam, Alan Mackay, et al.
Journal of the International AIDS Society|February 9, 2022
Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19Merle Henderson, Sarah Fidler, Beatriz Mothe, et al.
Cancer Research|May 6, 2004
Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell linesRuth L Stephen, Mattias C U Gustafsson, Morag Jarvis, et al.
Plos One|February 28, 2008
Phylometabonomic patterns of adaptation to high fat diet feeding in inbred miceJane F Fearnside, Marc-Emmanuel Dumas, Alice R Rothwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2006
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant miceMarc-Emmanuel Dumas, Richard H Barton, Ayo Toye, et al.
Plos One|May 19, 2016
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I TrialAgricola Joachim, Asli Bauer, Sarah Joseph, et al.
Frontiers in Immunology|March 10, 2017
A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization RegimesSarah Joseph, Killian Quinn, Aldona Greenwood, et al.
Frontiers in Immunology|May 21, 2019
Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and SequenceYuka Nadai, Kathrin Held, Sarah Joseph, et al.
Pageof 3